Pricing Log in Create free account

Erasca, Inc. (ERAS) vs Veradermics Incorporated (MANE)

Erasca, Inc. and Veradermics Incorporated are both Biotechnology companies. Veradermics Incorporated is the larger, with a market value of $5.4B against $4.6B — 1.2× the size. Across the 9 metrics below, Veradermics Incorporated leads on 6 and Erasca, Inc. on 3.

Valuation

Metric ERAS MANE Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 11.55 6.37 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (7.08%) (35.79%) (34.89%)
Free cash flow yield (6.03%) (2.37%) (24.52%)

Profitability

Metric ERAS MANE Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (78.25%) 0.00% (50.12%)
Return on assets (65.25%) (20.86%) (45.60%)
Return on invested capital (203.13%) 0.00% 0.00%

Growth

Metric ERAS MANE Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 36.23% (211.38%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ERAS MANE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.29 70.53 4.89
Net debt to EBITDA 1.93 1.96 1.01

Dividend

Metric ERAS MANE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ERAS MANE Biotechnology median
Market cap 4.64b 5.37b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack